In this randomized , double-blind , placebo-controlled trial , 18 - to 50-year-olds received 2 injections of placebo or norovirus GI .1 / GII .4 bivalent vaccine-like particle ( VLP ) vaccine with 3-O-desacyl-4 ' - monophosphoryl lipid A ( MPL ) and alum .